The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications

Mirjana Kovac, Gorana Mitic, Zeljko Mikovic, Vesna Mandic, Predrag Miljic, Mirjana Mitrovic, Branko Tomic, Z. Bereczky

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1 gene. The most common clinical presentation in AT deficient patients includes venous thrombosis and pulmonary embolism, while the association of AT deficiency and its effect on the development of pregnancy complications has been less studied. The aim of our research was to evaluate the effect of AT deficiency types, determined by genotyping, on pregnancy outcomes. Methods: A retrospective cohort study included 28 women with AT deficiency, and their 64 pregnancies were analyzed. Results: With regard to live birth rate, a significant difference was observed among women who were carriers of different SERPINC1 mutations, as the rate varied from 100% in cases of type I to the extremely low rate of 8% for women with type II HBS (AT Budapest 3) in the homozygous variant, P = 0.0005. All pregnancies from the type I group, even untreated ones, resulted in live births. In women with AT Budapest 3 in homozygous variant the overall live birth rate increased to 28.5% in the treated pregnancies. In this group the highest incidence of fetal death was observed of 62%; repeated fetal losses in 30%; fetal growth restriction in 22% and placental abruption in 7% of all pregnancies. Conclusion: Our study results indicate a difference between type I and type II AT deficiency. The risk of pregnancy related VTE was equally present in both groups, except for AT Budapest 3 in the heterozygous variant, while adverse pregnancy outcomes were strictly related to type II, especially AT Budapest 3 in the homozygous variant.

Original languageEnglish
Pages (from-to)12-19
Number of pages8
JournalThrombosis Research
Volume173
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Antithrombins
Pregnancy Complications
Mutation
Genes
Live Birth
Pregnancy
Birth Rate
Pregnancy Outcome
Abruptio Placentae
Fetal Death
Mutation Rate
Fetal Development
Fibrin
Pulmonary Embolism
Venous Thrombosis
Cohort Studies
Retrospective Studies
Incidence

Keywords

  • Antithrombin deficiency
  • Pregnancy outcome
  • SERPINC1 mutations

ASJC Scopus subject areas

  • Hematology

Cite this

The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications. / Kovac, Mirjana; Mitic, Gorana; Mikovic, Zeljko; Mandic, Vesna; Miljic, Predrag; Mitrovic, Mirjana; Tomic, Branko; Bereczky, Z.

In: Thrombosis Research, Vol. 173, 01.01.2019, p. 12-19.

Research output: Contribution to journalArticle

Kovac, Mirjana ; Mitic, Gorana ; Mikovic, Zeljko ; Mandic, Vesna ; Miljic, Predrag ; Mitrovic, Mirjana ; Tomic, Branko ; Bereczky, Z. / The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications. In: Thrombosis Research. 2019 ; Vol. 173. pp. 12-19.
@article{56cb48493bc1433887909e46a19aa37c,
title = "The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications",
abstract = "Background: Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1 gene. The most common clinical presentation in AT deficient patients includes venous thrombosis and pulmonary embolism, while the association of AT deficiency and its effect on the development of pregnancy complications has been less studied. The aim of our research was to evaluate the effect of AT deficiency types, determined by genotyping, on pregnancy outcomes. Methods: A retrospective cohort study included 28 women with AT deficiency, and their 64 pregnancies were analyzed. Results: With regard to live birth rate, a significant difference was observed among women who were carriers of different SERPINC1 mutations, as the rate varied from 100{\%} in cases of type I to the extremely low rate of 8{\%} for women with type II HBS (AT Budapest 3) in the homozygous variant, P = 0.0005. All pregnancies from the type I group, even untreated ones, resulted in live births. In women with AT Budapest 3 in homozygous variant the overall live birth rate increased to 28.5{\%} in the treated pregnancies. In this group the highest incidence of fetal death was observed of 62{\%}; repeated fetal losses in 30{\%}; fetal growth restriction in 22{\%} and placental abruption in 7{\%} of all pregnancies. Conclusion: Our study results indicate a difference between type I and type II AT deficiency. The risk of pregnancy related VTE was equally present in both groups, except for AT Budapest 3 in the heterozygous variant, while adverse pregnancy outcomes were strictly related to type II, especially AT Budapest 3 in the homozygous variant.",
keywords = "Antithrombin deficiency, Pregnancy outcome, SERPINC1 mutations",
author = "Mirjana Kovac and Gorana Mitic and Zeljko Mikovic and Vesna Mandic and Predrag Miljic and Mirjana Mitrovic and Branko Tomic and Z. Bereczky",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.thromres.2018.11.006",
language = "English",
volume = "173",
pages = "12--19",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications

AU - Kovac, Mirjana

AU - Mitic, Gorana

AU - Mikovic, Zeljko

AU - Mandic, Vesna

AU - Miljic, Predrag

AU - Mitrovic, Mirjana

AU - Tomic, Branko

AU - Bereczky, Z.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1 gene. The most common clinical presentation in AT deficient patients includes venous thrombosis and pulmonary embolism, while the association of AT deficiency and its effect on the development of pregnancy complications has been less studied. The aim of our research was to evaluate the effect of AT deficiency types, determined by genotyping, on pregnancy outcomes. Methods: A retrospective cohort study included 28 women with AT deficiency, and their 64 pregnancies were analyzed. Results: With regard to live birth rate, a significant difference was observed among women who were carriers of different SERPINC1 mutations, as the rate varied from 100% in cases of type I to the extremely low rate of 8% for women with type II HBS (AT Budapest 3) in the homozygous variant, P = 0.0005. All pregnancies from the type I group, even untreated ones, resulted in live births. In women with AT Budapest 3 in homozygous variant the overall live birth rate increased to 28.5% in the treated pregnancies. In this group the highest incidence of fetal death was observed of 62%; repeated fetal losses in 30%; fetal growth restriction in 22% and placental abruption in 7% of all pregnancies. Conclusion: Our study results indicate a difference between type I and type II AT deficiency. The risk of pregnancy related VTE was equally present in both groups, except for AT Budapest 3 in the heterozygous variant, while adverse pregnancy outcomes were strictly related to type II, especially AT Budapest 3 in the homozygous variant.

AB - Background: Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1 gene. The most common clinical presentation in AT deficient patients includes venous thrombosis and pulmonary embolism, while the association of AT deficiency and its effect on the development of pregnancy complications has been less studied. The aim of our research was to evaluate the effect of AT deficiency types, determined by genotyping, on pregnancy outcomes. Methods: A retrospective cohort study included 28 women with AT deficiency, and their 64 pregnancies were analyzed. Results: With regard to live birth rate, a significant difference was observed among women who were carriers of different SERPINC1 mutations, as the rate varied from 100% in cases of type I to the extremely low rate of 8% for women with type II HBS (AT Budapest 3) in the homozygous variant, P = 0.0005. All pregnancies from the type I group, even untreated ones, resulted in live births. In women with AT Budapest 3 in homozygous variant the overall live birth rate increased to 28.5% in the treated pregnancies. In this group the highest incidence of fetal death was observed of 62%; repeated fetal losses in 30%; fetal growth restriction in 22% and placental abruption in 7% of all pregnancies. Conclusion: Our study results indicate a difference between type I and type II AT deficiency. The risk of pregnancy related VTE was equally present in both groups, except for AT Budapest 3 in the heterozygous variant, while adverse pregnancy outcomes were strictly related to type II, especially AT Budapest 3 in the homozygous variant.

KW - Antithrombin deficiency

KW - Pregnancy outcome

KW - SERPINC1 mutations

UR - http://www.scopus.com/inward/record.url?scp=85056672197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056672197&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2018.11.006

DO - 10.1016/j.thromres.2018.11.006

M3 - Article

C2 - 30458337

AN - SCOPUS:85056672197

VL - 173

SP - 12

EP - 19

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -